- Open
- 8.25
- High
- 8.50
- Low
- 8.00
- Close
- 8.50
- Change
- +0.00 (0.00%)
- Volume
- 479,320
| 6 Aug 2026 | 07:00:05 | Delivery of Third Milestone and Grant of Options |
| 3 Aug 2026 | 07:00:09 | Director Share Purchase |
| 4 Jun 2026 | 07:00:04 | Grant of Long-Term Incentives |
| 2 Jun 2026 | 07:00:06 | Launch of new interactive investor hub |
| 1 Jun 2026 | 07:00:10 | PDMR/Director Shareholding, Issue of Equity & TVR |
| 4 Nov 2024 | Annual Report and Accounts (to 2024-04-30) | |
| 3 Nov 2023 | Annual Report and Accounts (to 2023-04-30) | |
| 14 Oct 2022 | Annual Report and Accounts (to 2022-04-30) |
Kromek Group plc develops and manufactures radiation detection and bio-detection technology solutions, utilizing cadmium zinc telluride (CZT) and related technologies. The company operates in advanced imaging markets, including medical, security, and industrial sectors, providing OEM customers with detector components for applications such as disease detection and contamination monitoring. Kromek also offers nuclear radiation detection solutions for the homeland defense and security market, focusing on protecting critical infrastructure from threats. The company generates revenue primarily through the sale of radiation equipment and technology development. Kromek is headquartered in County Durham, UK, with manufacturing operations in both the UK and the US.
| 6 Aug 2026 | 07:00:05 | Delivery of Third Milestone and Grant of Options |
| 3 Aug 2026 | 07:00:09 | Director Share Purchase |
| 4 Jun 2026 | 07:00:04 | Grant of Long-Term Incentives |
| 2 Jun 2026 | 07:00:06 | Launch of new interactive investor hub |
| 1 Jun 2026 | 07:00:10 | PDMR/Director Shareholding, Issue of Equity & TVR |
| 4 Nov 2024 | Annual Report and Accounts (to 2024-04-30) | |
| 3 Nov 2023 | Annual Report and Accounts (to 2023-04-30) | |
| 14 Oct 2022 | Annual Report and Accounts (to 2022-04-30) |
Kromek Group plc develops and manufactures radiation detection and bio-detection technology solutions, utilizing cadmium zinc telluride (CZT) and related technologies. The company operates in advanced imaging markets, including medical, security, and industrial sectors, providing OEM customers with detector components for applications such as disease detection and contamination monitoring. Kromek also offers nuclear radiation detection solutions for the homeland defense and security market, focusing on protecting critical infrastructure from threats. The company generates revenue primarily through the sale of radiation equipment and technology development. Kromek is headquartered in County Durham, UK, with manufacturing operations in both the UK and the US.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £440m | -0.4% | |
| £310m | -0.1% | |
KMKKromek Group PLC | £56m | +0.6% |
| £7m | -0.4% | |
| £1m | -0.7% | |
| £1m | +0.5% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £440m | -0.4% | |
| £310m | -0.1% | |
KMKKromek Group PLC | £56m | +0.6% |
| £7m | -0.4% | |
| £1m | -0.7% | |
| £1m | +0.5% |